Renal replacement therapy in neonates with hyperammonemia associated with inherited metabolic disease
10.3760/cma.j.issn.1673-4408.2022.07.010
- VernacularTitle:新生儿遗传代谢病相关高氨血症的肾脏替代治疗进展
- Author:
Xiaojing TANG
1
;
Yi WANG
;
Yujuan ZHAO
Author Information
1. 西安市儿童医院新生儿重症医学科 710003
- Keywords:
Hyperammonemia;
Neonates;
Peritoneal dialysis;
Continuous renal replacement therapy
- From:
International Journal of Pediatrics
2022;49(7):474-477
- CountryChina
- Language:Chinese
-
Abstract:
Neonatal hyperammonemia has great damage to the central nervous system, which can lead to severe disability and even death.Early reduction of blood ammonia and shortening the duration of hyperammonemia coma can improve the poor prognosis of the central nervous system.Renal replacement therapy can reduce blood ammonia quickly and effectively which is an important treatment for neonatal hyperammonemia.Common kidney replacement therapies include peritoneal dialysis, intermittent hemodialysis, continuous renal replacement therapy and hybrid therapy.This review aims to elaborate the indications of renal replacement therapy, the advantages and disadvantages of various renal replacement therapy modes in the treatment of neonatal hyperammonemia and hybrid therapy.
